PTV Network

GSK CEO

GlaxoSmithKline (GSK) has announced that its current Chief Executive Officer, Emma Walmsley, will step down at the end of this year. (Reuters)

Why GSK CEO Emma Walmsley is stepping down after seven years

GlaxoSmithKline CEO Emma Walmsley will step down at the end of 2025, with Luke Miels set to take over in January 2026. The leadership change signals a new focus on shareholder value and pipeline delivery as GSK targets ambitious growth.

September 30, 2025